DPP IV inhibitor formulations

A pharmaceutical composition comprising as an active ingredient a DPP IV inhibitor compound of formula

• in an amount of 5 mg, or a salt thereof, a first diluent, a second diluent, a binder, a disintegrant and a lubricant, wherein the first diluent is mannitol and the second diluent is pregelatinized starch
• wherein the pharmaceutical composition comprises:
• 0.5-20% by weight of active ingredient
• 40-88% by weight of first diluent,
• 3-40% by weight of second diluent,
• 1-5% by weight of binder,
• 5-15% by weight of disintegrant, and
• 0.1-4% by weight of lubricant.